Aisenberg Laura, Rasooly Irit R, Weiss Pamela F, Burnham Jon, Costello Anna
Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Division of General Pediatrics, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Diagnosis (Berl). 2025 May 23. doi: 10.1515/dx-2025-0031.
During the SARS-CoV-2 pandemic, new patient evaluations in pediatric rheumatology were performed using telehealth. Given the pediatric rheumatology workforce shortage, telehealth may be a way to efficiently triage referrals. The objective was to assess the utility of telehealth visits as a diagnostic tool to accurately assess the need for in-person evaluation.
This was a retrospective cohort study of patients evaluated by telehealth for a new patient visit from March 1 to June 30, 2020 at a tertiary center. Electronic health record documentation from subsequent rheumatology, specialty, and primary care encounters over the subsequent 4 years were reviewed. The primary outcome was diagnostic concordance, defined as consistency in the documented diagnostic reasoning, between the initial telehealth video visit and in-person follow-up visits.
During the study period, there were 111 telehealth visits, 80 (72 %) of which had follow-up data. 55/80 had in-person rheumatology evaluations. Only 9 % patients had discordant diagnoses, all of whom had initial concern for inflammatory arthritis during the telehealth visit but a diagnosis of a non-inflammatory condition after in-person evaluation. Nine patients with a significant rheumatic disease were identified via telehealth. There were no unplanned ED visits or hospital admissions following telehealth visits. 33 % of patients were found to not warrant rheumatologic follow-up after the telehealth visit.
For pediatric rheumatology new patient evaluations, diagnostic accuracy via telehealth evaluation was high. Providers triaged patients with chronic rheumatologic conditions for in-person evaluations and were able to accurately identify benign conditions that did not require in-person follow-up.
在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行期间,小儿风湿病领域采用远程医疗进行新患者评估。鉴于小儿风湿病领域劳动力短缺,远程医疗可能是一种有效分流转诊患者的方式。目的是评估远程医疗问诊作为一种诊断工具准确评估面对面评估需求的效用。
这是一项回顾性队列研究,研究对象为2020年3月1日至6月30日在一家三级医疗中心通过远程医疗进行新患者问诊评估的患者。回顾了随后4年中后续风湿病、专科和初级保健会诊的电子健康记录文档。主要结局是诊断一致性,定义为初始远程医疗视频问诊与面对面随访问诊之间记录的诊断推理的一致性。
在研究期间,共进行了111次远程医疗问诊,其中80次(72%)有随访数据。55/80的患者进行了面对面的风湿病评估。只有9%的患者诊断不一致,所有这些患者在远程医疗问诊期间最初都被怀疑患有炎性关节炎,但在面对面评估后被诊断为非炎性疾病。通过远程医疗确定了9例患有重大风湿性疾病的患者。远程医疗问诊后没有计划外的急诊就诊或住院情况。33%的患者在远程医疗问诊后被发现不需要风湿病随访。
对于小儿风湿病新患者评估,通过远程医疗评估的诊断准确性很高。医疗服务提供者对患有慢性风湿性疾病的患者进行了面对面评估的分流,并能够准确识别不需要面对面随访的良性疾病。